Dashboard
Manage Tickers

BDRX Biodexa Pharmaceuticals Plc

Nasdaq midatechpharma.com


$ 7.70 $ -0.57 (-6.83 %)    

Friday, 17-Oct-2025 18:21:28 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 604.92 $ 3.94 (0.66 %)
DIA $ 461.73 $ 2.22 (0.48 %)
SPY $ 665.28 $ 3.75 (0.57 %)
TLT $ 91.09 $ -0.14 (-0.15 %)
GLD $ 391.28 $ -7.46 (-1.88 %)
$ 7.77
$ 7.80
$ 6.93 x 50
$ 9.50 x 1
$ 7.52 - $ 8.15
$ 5.00 - $ 92.00
22,611
na
1.04B
$ 1.32
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles
12 Health Care Stocks Moving In Monday's I...
10/13/2025 17:06:02

Core News & Articles
12 Health Care Stocks Moving In Friday's I...
10/10/2025 17:06:47

Core News & Articles
12 Health Care Stocks Moving In Friday's P...
10/10/2025 12:07:59

why-did-biodexa-pharmaceuticals-stock-drop-after-hours-despite-big-gain-during-regular-trading
Why Did Biodexa Pharmaceuticals' Stock Dro...
10/10/2025 04:49:40

Biodexa's stock dipped 3.67% to $10.50 in after-hours trading following a strong gain during the regular session.

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
10/09/2025 17:06:06

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
10/09/2025 12:07:59

biodexa-pharmaceuticals--files-for-mixed-shelf-of-up-to-100m
Biodexa Pharmaceuticals Files For Mixed S...
09/26/2025 21:04:58

https://www.sec.gov/Archives/edgar/data/1643918/000121465925014255/b923250f3.htm

Core News & Articles
12 Health Care Stocks Moving In Monday's P...
09/08/2025 12:08:53

biodexa-launches-registrational-phase-3-trial-of-erapa-for-familial-adenomatous-polyposis
Biodexa Launches Registrational Phase 3 Tr...
09/08/2025 11:02:30

biodexa-enrolls-first-patients-into-phase-3-serenta-trial-for-adenomatous-polyposis
Biodexa Enrolls First Patients Into Phase ...
08/18/2025 12:32:05

biodexa-pharmaceuticals-implements-1-for-10-reverse-adr-split-new-ratio-now-1-adr-to-100k-ordinary-shares
Biodexa Pharmaceuticals Implements 1-For-1...
07/31/2025 13:31:27

Biodexa Pharmaceuticals PLC (NASDAQ:BDRX), a clinical stage biopharmaceutical company developing a pipeline of innovative produ...

trading-halt-halted-at-75000-pm-et---trading-halt-halt-news-pending
Trading Halt: Halted at 7:50:00 p.m. ET - ...
07/30/2025 23:50:04

biodexa-pharma-advances-development-erapa-oral-tablet-formulation-of-rapamycin-to-treat-fap-non-surgically
Biodexa Pharma Advances Development eRapa,...
07/28/2025 11:10:21

Biodexa Pharmaceuticals PLC. (NASDAQ:BDRX), a clinical-stage biopharmaceutical company, reports making significant progress in ...

biodexa-pharmaceuticals-announces-a-1-for-10-ratio-change-on-its-american-depositary-receipts-effective-on-july-31-2025
Biodexa Pharmaceuticals Announces A 1-For-...
07/15/2025 20:35:05

biodexa-pharma-files-cta-with-ema-for-serenta-trial-in-patients-with-familial-adenomatous-polyposis
Biodexa Pharma Files CTA With EMA For Sere...
07/14/2025 12:35:53

Biodexa Announces Filing of CTA in Europe for Phase 3 Serenta Trial inFamilial Adenomatous Polyposis (FAP)Biodexa Pharmaceutica...

biodexa-pharma-announces-activation-of-first-clinical-study-site-for-serenta-trial-in-patients-with-familial-adenomatous-polyposis
Biodexa Pharma Announces Activation Of Fir...
06/25/2025 12:34:14

Biodexa Announces Activation of First Clinical Study Site for Phase 3 Serenta Trial in Familial Adenomatous Polyposis (FAP)Biod...

Core News & Articles
12 Health Care Stocks Moving In Wednesday'...
06/18/2025 17:06:11

Core News & Articles
12 Health Care Stocks Moving In Wednesday'...
06/18/2025 12:08:53

Core News & Articles
Market-Moving News for June 18th
06/18/2025 11:29:11

SRRK: 23% | Scholar Rock shares are trading higher after a study showed its new drug combination preserves muscle during tirzep...

biodexa-enrolls-first-patient-in-phase-2a-study-of-tolimidone
Biodexa Enrolls First Patient In Phase 2a ...
06/18/2025 11:02:44

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION